PubMed

Efficacy and safety of angiotensin II receptor blockade in elderly patients with diabetes.

Winkelmayer WC, Zhang Z, Shahinfar S, Cooper ME, Avorn J, Brenner BM.

Diabetes Care. 2006 Oct;29(10):2210-7.PMID: 17003295 [PubMed - indexed for MEDLINE]Related articlesFree article

Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL.

de Zeeuw D, Remuzzi G, Parving HH, Keane WF, Zhang Z, Shahinfar S, Snapinn S, Cooper ME, Mitch WE, Brenner BM.

Kidney Int. 2004 Jun;65(6):2309-20.PMID: 15149345 [PubMed - indexed for MEDLINE]Related articles

Losartan in patients with type 2 diabetes and proteinuria: observations from the RENAAL Study.

Shahinfar S, Dickson TZ, Ahmed T, Zhang Z, Ramjit D, Smith RD, Brenner BM; RENAAL Investigators.

Kidney Int Suppl. 2002 Dec;(82):S64-7.PMID: 12410858 [PubMed - indexed for MEDLINE]Related articles

Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study.

Bakris GL, Weir MR, Shanifar S, Zhang Z, Douglas J, van Dijk DJ, Brenner BM; RENAAL Study Group.

Arch Intern Med. 2003 Jul 14;163(13):1555-65.PMID: 12860578 [PubMed - indexed for MEDLINE]Related articlesFree article

Renin angiotensin aldosterone system blockade and renal disease in patients with type 2 diabetes: a subanalysis of Japanese patients from the RENAAL study.

Kurokawa K, Chan JC, Cooper ME, Keane WF, Shahinfar S, Zhang Z.

Clin Exp Nephrol. 2006 Sep;10(3):193-200.PMID: 17009077 [PubMed - indexed for MEDLINE]Related articles

Renin angiotensin aldosterone system blockade and renal disease in patients with type 2 diabetes. An Asian perspective from the RENAAL Study.

Chan JC, Wat NM, So WY, Lam KS, Chua CT, Wong KS, Morad Z, Dickson TZ, Hille D, Zhang Z, Cooper ME, Shahinfar S, Brenner BM, Kurokawa K; Asian RENAAL Study Investigators.

Diabetes Care. 2004 Apr;27(4):874-9.PMID: 15047641 [PubMed - indexed for MEDLINE]Related articlesFree article

Design of combination angiotensin receptor blocker and angiotensin-converting enzyme inhibitor for treatment of diabetic nephropathy (VA NEPHRON-D).

Fried LF, Duckworth W, Zhang JH, O'Connor T, Brophy M, Emanuele N, Huang GD, McCullough PA, Palevsky PM, Seliger S, Warren SR, Peduzzi P; VA NEPHRON-D Investigators.

Clin J Am Soc Nephrol. 2009 Feb;4(2):361-8. Epub 2008 Dec 31.PMID: 19118120 [PubMed - indexed for MEDLINE]Related articles

Emerging trends for prevention and treatment of diabetic nephropathy: blockade of the RAAS and BP control.

Hunsicker LG.

J Manag Care Pharm. 2004 Sep;10(5 Suppl A):S12-7. Review.PMID: 15369420 [PubMed - indexed for MEDLINE]Related articlesFree article

Losartan reduces the burden and cost of ESRD: public health implications from the RENAAL study for the European Union.

Gerth WC, Remuzzi G, Viberti G, Hannedouche T, Martinez-Castelao A, Shahinfar S, Carides GW, Brenner B.

Kidney Int Suppl. 2002 Dec;(82):S68-72.PMID: 12410859 [PubMed - indexed for MEDLINE]Related articles

Recent advances in management of type 2 diabetes and nephropathy: lessons from the RENAAL study.

Keane WF, Lyle PA; Reduction of Endpoints in NIDDM with the Angiotensin II Receptor Antagonist Losartan study.

Am J Kidney Dis. 2003 Mar;41(3 Suppl 1):S22-5. Review.PMID: 12612946 [PubMed - indexed for MEDLINE]Related articles

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.

Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S; RENAAL Study Investigators.

N Engl J Med. 2001 Sep 20;345(12):861-9.PMID: 11565518 [PubMed - indexed for MEDLINE]Related articlesFree article

Use of losartan in diabetic patients in the primary care setting: review of the results in LIFE and RENAAL.

Egan B, Gleim G, Panish J.

Curr Med Res Opin. 2004 Dec;20(12):1909-17.PMID: 15701209 [PubMed - indexed for MEDLINE]Related articles

Losartan and end-organ protection--lessons from the RENAAL study.

Kowey PR, Dickson TZ, Zhang Z, Shahinfar S, Brenner BM; RENAAL Investigators.

Clin Cardiol. 2005 Mar;28(3):136-42.PMID: 15813620 [PubMed - indexed for MEDLINE]Related articles

The impact of losartan on the lifetime incidence of end-stage renal disease and costs in patients with type 2 diabetes and nephropathy.

Carides GW, Shahinfar S, Dasbach EJ, Keane WF, Gerth WC, Alexander CM, Herman WH, Brenner BM; RENAAL Investigators.

Pharmacoeconomics. 2006;24(6):549-58.PMID: 16761903 [PubMed - indexed for MEDLINE]Related articles

ACE gene polymorphism and losartan treatment in type 2 diabetic patients with nephropathy.

Parving HH, de Zeeuw D, Cooper ME, Remuzzi G, Liu N, Lunceford J, Shahinfar S, Wong PH, Lyle PA, Rossing P, Brenner BM.

J Am Soc Nephrol. 2008 Apr;19(4):771-9. Epub 2008 Jan 16.PMID: 18199798 [PubMed - indexed for MEDLINE]Related articlesFree article

Losartan reduces the costs of diabetic end-stage renal disease: an Asian perspective.

Seng WK, Hwang SJ, Han DC, Teong CC, Chan J, Burke TA, Carides GW, Choi YJ.

Nephrology (Carlton). 2005 Oct;10(5):520-4.PMID: 16221106 [PubMed - indexed for MEDLINE]Related articles

Losartan reduces the costs associated with diabetic end-stage renal disease: the RENAAL study economic evaluation.

Herman WH, Shahinfar S, Carides GW, Dasbach EJ, Gerth WC, Alexander CM, Cook JR, Keane WF, Brenner BM.

Diabetes Care. 2003 Mar;26(3):683-7.PMID: 12610022 [PubMed - indexed for MEDLINE]Related articlesFree article

Losartan in diabetic nephropathy.

Perico N, Ruggenenti P, Remuzzi G.

Expert Rev Cardiovasc Ther. 2004 Jul;2(4):473-83. Review.PMID: 15225108 [PubMed - indexed for MEDLINE]Related articles

[Effect of losartan on renal and cardiovascular complications of patients with type 2 diabetes and nephropathy]

Parving HH, Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S.

Ugeskr Laeger. 2001 Oct 1;163(40):5514-9. Danish. PMID: 11601117 [PubMed - indexed for MEDLINE]Related articles

Losartan in diabetic nephropathy.

Carswell CI, Goa KL.

Drugs. 2003;63(4):407-14; discussion 415-6. Review.PMID: 12558462 [PubMed - indexed for MEDLINE]Related articles